Clarksdale Public Utilities

PFAS monitoring results for a public water system in Mississippi

MS0140002UCMR 5EPA monitoring data
<MRLHighest PFOA result, ppt
<MRLHighest PFOS result, ppt
0Highest Hazard Index
395Results
PWSID
MS0140002
State
Mississippi
System type
community water system (CWS)
Population served
14,903
City
Clarksdale
Counties
Coahoma County
Primary source water
groundwater
UCMR 5 sampling
2023-10-18 to 2024-04-25 · 7 entry point(s) · water types: GW
Service-area boundary
authoritative

No PFAS detected highest single result
No PFAS detected worst entry-point average

These are monitoring results collected under EPA's Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) at entry points, where treated water enters the distribution system; they are not tap-water samples. They are not compliance determinations: compliance with EPA's 2024 PFAS limits is judged on running annual averages of compliance monitoring, required from 2029, so a single UCMR 5 result at or above a limit is not a violation. “< MRL” means the compound was not quantified at EPA's minimum reporting level; it does not mean zero.

Compared with EPA's 2024 values

Highest single resultWorst entry-point average*Limit
PFOA (ppt)<MRL04
PFOS (ppt)<MRL04
Hazard Index001.0†

“<MRL” = every result for the compound was below its reporting limit. * Mean of all samples at each entry point with non-detects = 0 (EPA compliance convention; the Hazard Index also uses non-detects = 0); a screening comparison, not a formal running annual average. † Rescission proposed May 2026. PFOA/PFOS MCL 4 ppt (2024 NPDWR, in effect). PFHxS, PFNA, HFPO-DA (10 ppt each) and the Hazard Index (1.0) are 2024 NPDWR values; EPA proposed rescinding them on 18 May 2026 (comment period closed 20 Jul 2026).

No Mississippi PFAS drinking-water standard in effect or proposed as of 2026-10-17: No state PFAS drinking-water standard; follows federal NPDWR (BCLP state survey, Jan 2026).

Sampling history

Sampled 2023-10-18 to 2024-04-25 · 7 entry point(s) · water types: GW · 14 sampling visits. PFAS in ppt (ng/L).

DateEntry pointEventPFOAPFOSHIOther detections
2023-10-1819th & Center St. Treatment Facility (GW)SE1<4<40lithium 15.9 µg/L
2023-10-18Central Fire Station Treatment Facility (GW)SE1<4<40lithium 30 µg/L
2023-10-18DeSoto Ave. Treatment Facility (GW)SE1<4<40lithium 24.4 µg/L
2023-10-18Edwards Ave. Treatment Facility (GW)SE1<4<40lithium 29.8 µg/L
2023-10-18Fairland Ave. Treatment Facility (GW)SE1<4<40lithium 25.7 µg/L
2023-10-18Lyon Road Treatment Facility (GW)SE1<4<40lithium 25.8 µg/L
2023-10-18Well #3 Treatment Facility (GW)SE1<4<40lithium 21.3 µg/L
2024-04-2519th & Center St. Treatment Facility (GW)SE2<4<40lithium 15.9 µg/L
2024-04-25Central Fire Station Treatment Facility (GW)SE2<4<40lithium 27.1 µg/L
2024-04-25DeSoto Ave. Treatment Facility (GW)SE2n/an/an/alithium 27.5 µg/L
2024-04-25Edwards Ave. Treatment Facility (GW)SE2<4<40lithium 26.7 µg/L
2024-04-25Fairland Ave. Treatment Facility (GW)SE2<4<40lithium 32.6 µg/L
2024-04-25Lyon Road Treatment Facility (GW)SE2<4<40lithium 18.2 µg/L
2024-04-25Well #3 Treatment Facility (GW)SE2<4<40lithium 21.6 µg/L

“<4” = not detected at the reporting limit shown; “n/a” = not analyzed in that sample. Highlighted = at or above the 4 ppt MCL. HI computed per sample with non-detects as 0. Other detections lists every other quantified compound (lithium in µg/L).

All results by entry point

395 results. Each column is one sampling visit (date and UCMR 5 sample event). A number is a measured concentration; “< 4” = below the minimum reporting level shown; “–” = not analyzed in that visit. PFAS in ppt (ng/L); lithium in µg/L.

19th & Center St. Treatment Facility facility 31867 · sample point 31867 · groundwater

CompoundMRL2023-10-18
SE1
2024-04-25
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L15.915.9

Central Fire Station Treatment Facility facility 31863 · sample point 31863 · groundwater

CompoundMRL2023-10-18
SE1
2024-04-25
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L3027.1

DeSoto Ave. Treatment Facility facility 31866 · sample point 31866 · groundwater

CompoundMRL2023-10-18
SE1
2024-04-25
SE2
11Cl-PF3OUdS5 ppt< 5–
4:2 FTS3 ppt< 3–
6:2 FTS5 ppt< 5–
8:2 FTS5 ppt< 5–
9Cl-PF3ONS2 ppt< 2–
ADONA3 ppt< 3–
HFPO-DA5 ppt< 5–
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20–
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5–
PFBS3 ppt< 3–
PFDA3 ppt< 3–
PFDoA3 ppt< 3–
PFEESA3 ppt< 3–
PFHpA3 ppt< 3–
PFHpS3 ppt< 3–
PFHxA3 ppt< 3–
PFHxS3 ppt< 3–
PFMBA3 ppt< 3–
PFMPA4 ppt< 4–
PFNA4 ppt< 4–
PFOA4 ppt< 4–
PFOS4 ppt< 4–
PFPeA3 ppt< 3–
PFPeS4 ppt< 4–
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2–
lithium9 µg/L24.427.5

Edwards Ave. Treatment Facility facility 31864 · sample point 31864 · groundwater

CompoundMRL2023-10-18
SE1
2024-04-25
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L29.826.7

Fairland Ave. Treatment Facility facility 31865 · sample point 31865 · groundwater

CompoundMRL2023-10-18
SE1
2024-04-25
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L25.732.6

Lyon Road Treatment Facility facility 31869 · sample point 31869 · groundwater

CompoundMRL2023-10-18
SE1
2024-04-25
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L25.818.2

Well #3 Treatment Facility facility 31868 · sample point 31868 · groundwater

CompoundMRL2023-10-18
SE1
2024-04-25
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L21.321.6

Statistics by compound

CompoundResultsDetectedHighest (date)Mean boundsKM medianP75P90P95
lithium14100%32.6
2024-04-25
24.46–24.4625.727.53032.6

Never detected (29): 11Cl-PF3OUdS, 4:2 FTS, 6:2 FTS, 8:2 FTS, 9Cl-PF3ONS, ADONA, HFPO-DA, NEtFOSAA, NFDHA, NMeFOSAA, PFBA, PFBS, PFDA, PFDoA, PFEESA, PFHpA, PFHpS, PFHxA, PFHxS, PFMBA, PFMPA, PFNA, PFOA, PFOS, PFPeA, PFPeS, PFTA, PFTrDA, PFUnA.

Left-censored Kaplan–Meier statistics (Helsel 2005; Helsel & Lee 2006, NADA for R). Units: ppt; lithium µg/L. Each compound has one reporting limit, so the Kaplan–Meier mean equals the upper mean bound (non-detects at the MRL); the lower bound sets non-detects to 0. “<MRL” = the percentile falls below the reporting limit and cannot be estimated. These describe this system's UCMR 5 samples, not population estimates.

Sources

  • EPA UCMR 5 occurrence data text files (UCMR5_All.txt; samples 2023-01-23 to 2026-03-18; data summary dated Jul 2026)
  • EPA SDWIS via ECHO SDWA downloads, quarter 2026Q3
  • EPA Public Water System Service Areas v3 (Mar 2026)
  • US Census Bureau cartographic boundary counties 1:500k, 2024
  • EPA/USGS NHDPlus V2 (medium resolution) flowlines, Strahler order 2+

Data build 159b8c2ccdd2 · 2026-10-18T04:08Z · UCMR 5 release Jul2026 · SDWIS 2026Q3. Data and methods.